Pacific Biosciences Of California PACB
NASDAQ PACB
$2.38 +0.55 (+29.93%)
As of: Sep 30, 2026 · 12:08 PM EDT

Pacific Biosciences Of California (PACB) Total Current Liabilities (2010 - 2026)

Updated

Pacific Biosciences Of California (PACB) posted Total Current Liabilities of $68.81 million for Q2 2026, up 15.1% from $59.75 million a year earlier and up 5.3% from the prior quarter.

Analysis

Pacific Biosciences Of California (PACB) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Pacific Biosciences Of California's Total Current Liabilities came in at $72.83 million, up 9.9% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
  • In prior years, Pacific Biosciences Of California's Total Current Liabilities was $66.3 million in FY2024 (-30.2%), $95.03 million in FY2023 (-63.9%), $263.34 million in FY2022 (+267.2%) and $71.71 million in FY2021 (+86.2%).
  • Quarterly Total Current Liabilities has run from a low of $55.61 million in Q3 2021 to a high of $271.41 million in Q2 2023 over five years.
  • On a year-over-year basis, Total Current Liabilities increased in three of the last eight quarters, with an average decline of 12.7%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q1 2023, with growth of 335.5%; the weakest was Q1 2024, with a decline of 72.5%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $65.36 million (Q1 2026), $72.83 million (Q4 2025) and $63.21 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 15.07 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 17.81 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 8.11 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 1.92 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 11.80 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 6.68 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 6.43 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 9.40 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 1.51 Bn
10 Pacific Biosciences Of California 531.49 Mn -559.51 Mn 12.64 Mn 68.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.81 Mn
Mar 31, 2026 65.36 Mn
Dec 31, 2025 72.83 Mn
Sep 30, 2025 63.21 Mn
Jun 30, 2025 59.75 Mn
Mar 31, 2025 66.60 Mn
Dec 31, 2024 66.30 Mn
Sep 30, 2024 60.00 Mn
Jun 30, 2024 78.39 Mn
Mar 31, 2024 72.95 Mn
Dec 31, 2023 95.03 Mn
Sep 30, 2023 183.96 Mn
Jun 30, 2023 271.41 Mn
Mar 31, 2023 265.67 Mn
Dec 31, 2022 263.34 Mn
Sep 30, 2022 81.65 Mn
Jun 30, 2022 84.40 Mn
Mar 31, 2022 61.01 Mn
Dec 31, 2021 71.71 Mn
Sep 30, 2021 55.61 Mn
API Access

Pacific Biosciences Of California Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=PACB&period=max&api_key=YOUR_API_KEY